Literature DB >> 15840566

Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains.

Lennart Zabeau1, Delphine Defeau, Hannes Iserentant, Joël Vandekerckhove, Frank Peelman, Jan Tavernier.   

Abstract

The leptin receptor (LR) complex is composed of a single subunit belonging to the class I cytokine receptor family and exists as a preformed complex. The extracellular portion contains two cytokine receptor homology (CRH) domains, separated by an Ig-like domain and followed by two membrane-proximal fibronectin type III (FNIII) domains. The mechanisms underlying ligand-induced receptor activation are still poorly understood. LRs can exist as disulfide-linked dimers at the cell surface, even in the absence of leptin. We evaluated the role of the two unpaired cysteine residues (Cys-672 and Cys-751) in the FNIII domains in receptor clustering, leptin binding, and biological activity. Although mutation of cysteine on position 751 to serine has hardly any effect on ligand binding and receptor activation, the C672S mutant exhibits a marked reduction in STAT3-dependent signaling. The double mutant was completely devoid of biological activity, although leptin binding remained unaffected. Mutation of both residues resulted in complete loss of disulfide bridge formation of FNIII domains in solution. In contrast, no difference was observed in ligand-independent oligomerization of the membrane-bound receptor, suggesting a role for cysteines in the CRH2 domain in formation of the preformed LR complex. We propose a model wherein leptin-induced clustering of two preformed dimers forms the activated LR complex. Disulfide bridge formation involving Cys-672 and Cys-751 may be necessary for JAK activation and hence signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840566     DOI: 10.1074/jbc.M413308200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Structural basis of the proinflammatory signaling complex mediated by TSLP.

Authors:  Kenneth Verstraete; Loes van Schie; Laurens Vyncke; Yehudi Bloch; Jan Tavernier; Ewald Pauwels; Frank Peelman; Savvas N Savvides
Journal:  Nat Struct Mol Biol       Date:  2014-03-16       Impact factor: 15.369

2.  Molecular dynamics, dynamic site mapping, and highthroughput virtual screening on leptin and the Ob receptor as anti-obesity target.

Authors:  Marco Tutone; Licia Pantano; Antonino Lauria; Anna Maria Almerico
Journal:  J Mol Model       Date:  2014-05-06       Impact factor: 1.810

3.  Functional consequences of the human leptin receptor (LEPR) Q223R transversion.

Authors:  George Stratigopoulos; Charles A LeDuc; Naoki Matsuoka; Roee Gutman; Richard Rausch; Scott A Robertson; Martin G Myers; Wendy K Chung; Streamson C Chua; Rudolph L Leibel
Journal:  Obesity (Silver Spring)       Date:  2008-11-06       Impact factor: 5.002

4.  Ligand-induced architecture of the leptin receptor signaling complex.

Authors:  Liliya V Mancour; Hikmat N Daghestani; Somnath Dutta; Gerwin H Westfield; Justin Schilling; Austin N Oleskie; Jeffrey F Herbstman; Steven Z Chou; Georgios Skiniotis
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

5.  Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways.

Authors:  Joris Wauman; Anne-Sophie De Smet; Dominiek Catteeuw; Denise Belsham; Jan Tavernier
Journal:  Mol Endocrinol       Date:  2007-12-28

6.  Novel folate binding protein-1 interactions in embryonic orofacial tissue.

Authors:  M Michele Pisano; Vasker Bhattacherjee; Leeyean Wong; Richard H Finnell; Robert M Greene
Journal:  Life Sci       Date:  2010-01-05       Impact factor: 5.037

7.  Mutational Landscape Screening Through Comprehensive In Silico Analysis for Polycystic Ovarian Syndrome-Related Genes.

Authors:  Shrinjana Dhar; Saptarshi Mridha; Pritha Bhattacharjee
Journal:  Reprod Sci       Date:  2021-10-25       Impact factor: 3.060

8.  RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding.

Authors:  Joris Wauman; Leentje De Ceuninck; Nele Vanderroost; Sam Lievens; Jan Tavernier
Journal:  J Cell Sci       Date:  2011-03-15       Impact factor: 5.285

Review 9.  The role of leptin in innate and adaptive immune responses.

Authors:  Eiva Bernotiene; Gaby Palmer; Cem Gabay
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 10.  New pharmacological perspectives for the leptin receptor in the treatment of obesity.

Authors:  Clara Roujeau; Ralf Jockers; Julie Dam
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.